CUSIP: G6S41R101
What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G6S41R101:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 0 | $0 | -$613 | 0 | |
| 2023 Q4 | 204,262 | $613 | -$1,565,148 | $0.00 | 2 |
| 2023 Q3 | 18,060,944 | $1,565,761 | -$3,633,900 | $0.09 | 27 |
| 2023 Q2 | 24,083,548 | $13,488,979 | -$736,573 | $0.56 | 35 |
| 2023 Q1 | 25,178,425 | $28,704,225 | +$51,334 | $1.14 | 40 |
| 2022 Q4 | 25,120,022 | $28,016,566 | +$859,275 | $1.12 | 34 |
| 2022 Q3 | 24,041,272 | $50,486,465 | +$16,177,875 | $2.10 | 43 |
| 2022 Q2 | 16,362,756 | $22,201,010 | -$85,746 | $1.36 | 32 |
| 2022 Q1 | 16,443,193 | $27,791,181 | -$738,822 | $1.69 | 32 |
| 2021 Q4 | 17,303,008 | $18,657,000 | +$13,947,606 | $1.08 | 28 |
| 2021 Q3 | 4,007,272 | $11,819,127 | -$2,375,042 | $2.95 | 33 |
| 2021 Q2 | 4,826,957 | $14,531,084 | -$9,546,822 | $3.00 | 44 |
| 2021 Q1 | 7,873,723 | $25,661,886 | -$51,365 | $3.26 | 53 |
| 2020 Q4 | 7,519,318 | $30,977,413 | -$3,822,734 | $4.12 | 59 |
| 2020 Q3 | 8,326,833 | $45,048,984 | +$11,342,884 | $5.41 | 60 |
| 2020 Q2 | 6,099,346 | $41,044,271 | +$2,816,189 | $6.73 | 63 |
| 2020 Q1 | 6,373,763 | $20,268,967 | +$8,751,680 | $3.18 | 59 |
| 2019 Q4 | 3,517,711 | $24,590,448 | +$12,386,966 | $6.99 | 49 |
| 2019 Q3 | 1,901,052 | $7,295,950 | -$6,329,877 | $3.84 | 39 |
| 2019 Q2 | 3,571,564 | $13,571,855 | -$8,584,884 | $3.80 | 42 |
| 2019 Q1 | 5,995,096 | $21,582,000 | -$2,804,869 | $3.60 | 34 |
| 2018 Q4 | 6,573,536 | $50,941,000 | +$50,941,000 | $7.75 | 34 |